| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Nicolas Leveque | Q42872073 |
| P2093 | author name string | Paul Fornes | |
| Camille Brasselet | |||
| Camille Boulagnon | |||
| Laurent Andréoletti | |||
| P433 | issue | 6-7 | |
| P304 | page(s) | 559-568 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | Archives of Cardiovascular Diseases | Q2366616 |
| P1476 | title | Viral causes of human myocarditis | |
| P478 | volume | 102 |
| Q47222596 | A novel rat CVB1-VP1 monoclonal antibody 3A6 detects a broad range of enteroviruses. |
| Q35123281 | ATP-sensitive potassium channel (K(ATP))-dependent regulation of cardiotropic viral infections |
| Q57149070 | Acute and Fulminant Myocarditis: a Pragmatic Clinical Approach to Diagnosis and Treatment |
| Q37895688 | Acute myocarditis in children |
| Q38075209 | Acute pneumonia and the cardiovascular system. |
| Q33163355 | Acute right ventricular myocarditis presenting with chest pain and syncope |
| Q38749171 | Amiloride is a competitive inhibitor of coxsackievirus B3 RNA polymerase |
| Q44037150 | Autoimmune-like syndromes during TNF blockade: does infection have a role? |
| Q40266436 | Autosomal Recessive Cardiomyopathy Presenting as Acute Myocarditis |
| Q35096144 | Bioinformatics multivariate analysis determined a set of phase-specific biomarker candidates in a novel mouse model for viral myocarditis |
| Q41675000 | Cardiac fibroblasts aggravate viral myocarditis: cell specific coxsackievirus B3 replication |
| Q36175795 | Computational Analysis of Amiloride Analogue Inhibitors of Coxsackievirus B3 RNA Polymerase |
| Q38108397 | Control of inflammatory heart disease by CD4+ T cells. |
| Q24202995 | Corticosteroids for viral myocarditis |
| Q37659242 | Coxsackie Myocarditis and Hepatitis with Reactivated Epstein-Bar Virus (EBV): A Case Report. |
| Q42224664 | Coxsackievirus B1 reveals strain specific differences in plasmacytoid dendritic cell mediated immunogenicity |
| Q37486647 | Coxsackievirus B3 Directly Induced Th17 Cell Differentiation by Inhibiting Nup98 Expression in Patients with Acute Viral Myocarditis |
| Q36177764 | Coxsackievirus B3 induces the formation of autophagosomes in cardiac fibroblasts both in vitro and in vivo |
| Q55248618 | Cytomegalovirus myocarditis in a patient with systemic lupus erythematosus (SLE) successfully treated with ganciclovir. |
| Q38244749 | Death waits for no man--does it wait for a virus? How enteroviruses induce and control cell death |
| Q40333639 | Detection of human parvovirus B19 DNA in 22% of 1815 cutaneous biopsies of a wide variety of dermatological conditions suggests viral persistence after primary infection and casts doubts on its pathogenic significance. |
| Q35260617 | Development of viral vectors for use in cardiovascular gene therapy |
| Q90394786 | Diagnostic and prognostic role of cardiac magnetic resonance in acute myocarditis |
| Q93140621 | Differential expression of coxsackievirus and adenovirus receptor in endomyocardial tissue of patients with myocarditis |
| Q36507273 | Direct Identification of Enteroviruses in Cerebrospinal Fluid of Patients with Suspected Meningitis by Nested PCR Amplification. |
| Q90032553 | Emerging role of microRNAs in dilated cardiomyopathy: evidence regarding etiology |
| Q92715746 | Endomyocardial biopsy in patients with acute myocarditis, idiopathic dilated cardiomyopathy, and arrhythmogenic right ventricular dysplasia |
| Q37704544 | Enter at your own risk: how enteroviruses navigate the dangerous world of pattern recognition receptor signaling |
| Q40866127 | Fatal Myocarditis Associated With HHV-6 Following Immunosuppression in Two Children |
| Q37591179 | Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A. |
| Q90073141 | Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases |
| Q24185801 | Herbal medicines for viral myocarditis |
| Q24200215 | Herbal medicines for viral myocarditis |
| Q24202848 | Herbal medicines for viral myocarditis |
| Q24234136 | Herbal medicines for viral myocarditis |
| Q24246795 | Herbal medicines for viral myocarditis |
| Q39392116 | Human CD4+ T cell response to human herpesvirus 6. |
| Q38874111 | Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine. |
| Q42266190 | Human parvovirus B19 infection leads to downregulation of thyroid, estrogen, and retinoid hormone receptor expression |
| Q41929925 | Immunological and pathological consequences of coxsackievirus RNA persistence in the heart |
| Q37713958 | In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease |
| Q30416720 | Influenza A/H1N1 (2009) infection as a cause of unexpected out-of-hospital death in the young. |
| Q36294384 | Interleukin-27 ameliorates coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cells |
| Q34937306 | Macrophage diversity in cardiac inflammation: a review |
| Q49220052 | Mesenchymal stromal cells inhibit NLRP3 inflammasome activation in a model of Coxsackievirus B3-induced inflammatory cardiomyopathy |
| Q48045237 | Molecular characteristics of human coxsackievirus B1 infection in Korea, 2008-2009. |
| Q40108598 | Multiple Organ Failure Associated With Coxsackie Virus in a Kidney Transplant Patient: Case Report. |
| Q100526188 | Myocarditis and inflammatory cardiomyopathy: current evidence and future directions |
| Q89668418 | Myocarditis presenting as typical acute myocardial infarction: A case report and review of the literature |
| Q41879078 | Myocarditis, hepatitis, and pancreatitis in a patient with coxsackievirus A4 infection: a case report |
| Q35143773 | Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration. |
| Q58666387 | Parvovirus B19 Achievements and Challenges |
| Q38180743 | Regulation of the immune response during infectious myocarditis. |
| Q90068173 | Related Enteric Viruses Have Different Requirements for Host Microbiota in Mice |
| Q43991766 | Relationship of cardiac magnetic resonance imaging and myocardial biopsy in the evaluation of nonischemic cardiomyopathy |
| Q41752576 | Rethinking Molecular Mimicry in Rheumatic Heart Disease and Autoimmune Myocarditis: Laminin, Collagen IV, CAR, and B1AR as Initial Targets of Disease |
| Q38055888 | Role of molecular diagnostics in the management of infectious disease emergencies. |
| Q39013837 | Sex-Dependent Intestinal Replication of an Enteric Virus |
| Q42287219 | Successful clearance of human parainfluenza virus type 2 viraemia with intravenous ribavirin and immunoglobulin in a patient with acute myocarditis |
| Q64298437 | Suppressed androgen receptor expression promotes M2 macrophage reprogramming through the STAT3/SOCS3 pathway |
| Q42153196 | Synthesis and antiviral activity of 1-(1,3-disubstitutedimidazolidyn-2-ylidene)-3-ethoxycarbonylmethylurea derivatives |
| Q34612207 | Th17-related cytokines in systemic lupus erythematosus patients with dilated cardiomyopathies: a possible linkage to parvovirus B19 infection |
| Q91714343 | Triggers of Inflammatory Heart Disease |
| Q35824295 | Unc93b Induces Apoptotic Cell Death and Is Cleaved by Host and Enteroviral Proteases |
| Q34452486 | Unresolved issues in theories of autoimmune disease using myocarditis as a framework |
| Q38009617 | Viral targets of acylguanidines |
| Q36971127 | Virus detection and semiquantitation in explanted heart tissues of idiopathic dilated cardiomyopathy adult patients by use of PCR coupled with mass spectrometry analysis |
| Q26738973 | What Is the Arrhythmic Substrate in Viral Myocarditis? Insights from Clinical and Animal Studies |
Search more.